References
- Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392;245-252, 1998 https://doi.org/10.1038/32588
- Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 18;767-811, 2000 https://doi.org/10.1146/annurev.immunol.18.1.767
- Steinman RM, Dhodapkar M: Active immunization against cancer with dendritic cells: the near future. Int J Cancer 94;459-473, 2001 https://doi.org/10.1002/ijc.1503
- Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ: Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183;87-97, 1996 https://doi.org/10.1084/jem.183.1.87
- Kaplan JM, Yu Q, Piraino ST, Pennington SE, Shankara S, Woodworth LA, Roberts BL: Induction of antitumor immunity with dendritic cells transduced with adenovirus vector- encoding endogenous tumor-associated antigens. J Immunol 163;699-707, 1999
- Iacobelli S, Arno E, D'Orazio A, Coletti G: Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res 46;3005-3010, 1986
- Rosenberg I, Cherayil BJ, Isselbacher KJ, Pillai S: Mac-2- binding glycoproteins. Putative ligands for a cytosolic beta- galactoside lectin. J Biol Chem 266;18731-18736,1991
- Koths K, Taylor E, Halenbeck R, Casipit C, Wang A: Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem 268;14245-14249, 1993
- Ullrich A, Sures I, D'Egidio M, Jallal B, Powell TJ, Herbst R, Dreps A, Azam M, Rubinstein M, Natoli C, et al: The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem 269;18401-18407, 1994
- Iacovazzi PA, Trisolini A, Barletta D, Elba S, Manghisi OG, Correale M: Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein. Clin Chem Lab Med 39;961- 965, 2001 https://doi.org/10.1515/CCLM.2001.155
- Fusco O, Querzoli P, Nenci I, Natoli C, Brakebush C, Ullrich A, Iacobelli S: 90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells. Int J Cancer 79;23-26, 1998 https://doi.org/10.1002/(SICI)1097-0215(19980220)79:1<23::AID-IJC5>3.0.CO;2-Y
- Park YP, Choi SC, Kim JH, Song EY, Kim JW, Yoon DY, Yeom YI, Lim JS, Kim JW, Paik SG, Lee HG: Up-regulation of Mac-2 binding protein by hTERT in gastric cancer. Int J Cancer 120;813-820, 2007 https://doi.org/10.1002/ijc.22369
- Ozaki Y, Kontani K, Hanaoka J, Chano T, Teramoto K, Tezuka N, Sawai S, Fujino S, Yoshiki T, Okabe H, Ohkubo I: Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma. Cancer 95;1954-1962, 2002 https://doi.org/10.1002/cncr.10899
- Becker R, Lenter MC, Vollkommer T, Boos AM, Pfaff D, Augustin HG, Christian S: Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K. FASEB J 22;3059-3067, 2008 https://doi.org/10.1096/fj.07-101386
- Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, et al: Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med 1;1297-1302, 1995 https://doi.org/10.1038/nm1295-1297
- Porgador A, Gillboa E: Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 182;255-260, 1995 https://doi.org/10.1084/jem.182.1.255
- Boczkowski D, Nair SK, Snyder D, Gilboa E: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184;465-472, 1996 https://doi.org/10.1084/jem.184.2.465
- Boczkowski D, Nair SK, Snyder D, Gilboa E: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184;465-472, 1996 https://doi.org/10.1084/jem.184.2.465
Cited by
- Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K vol.10, pp.3, 2010, https://doi.org/10.1038/cmi.2012.74
- Review on the immunotherapy strategies against metastatic colorectal carcinoma vol.8, pp.10, 2010, https://doi.org/10.2217/imt-2016-0045
- Immunocyte Profiling Using Single-Cell Mass Cytometry Reveals EpCAM+ CD4+ T Cells Abnormal in Colon Cancer vol.10, pp.None, 2010, https://doi.org/10.3389/fimmu.2019.01571
- Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling vol.7, pp.1, 2010, https://doi.org/10.1038/s41420-021-00447-7